0.9 C
New York
Thursday, February 6, 2025

Injectable blood pressure drug recalled over fear of contamination

An injectable blood pressure drug called phenylephrine hydrochloride has been recalled after a customer noticed “a visible black particulate matter” in a vial of the product, raising the risk of stroke or death, according to the U.S. Food and Drug Administration (FDA).

Provepharm, Inc., of Pennsylvania, announced their nationwide voluntary recall on Friday, January 24, and the FDA followed suit the same day.

The recall affects one lot of phenylephrine hydrochloride injection, 10mg/ml, sold to wholesalers, distributors, compounding companies and hospitals.

The drug is used to treat low blood pressure, also known as hypotension, mainly after anesthesia when the blood vessels dilate.

“This recall was initiated based on a customer complaint from a pharmacy after observing a visible black particulate matter found in a single-sealed vial of the product,” said the FDA announcement.

Injecting particulate matter can cause side effects, such as irritation or swelling in the place where it was injected, as the body responds to the presence of foreign material.

Also Read  You're free to relocate, registrar tells nurses

If it enters the blood vessels, particulate matter could travel around the body to various organs, potentially blocking blood vessels in the heart, lungs or brain.

These blockages could lead to serious complications, including stroke or even death.

No adverse events or injuries had been reported to Provepharm as of its announcement on Friday.

Individuals who have experienced any problems that may be related to taking or using this drug product are advised to contact their physician or healthcare provider for medical attention.

Newsweek has approached Provepharm for comment via email form outside of normal business hours.

Source: Newsweek

Agency
+ posts

Related Articles

Stay Connected

3,500FansLike
3,028FollowersFollow
500FollowersFollow

Latest Articles